HIV Citation List: March 14 - March 27, 2014
PubMed citations
1. Activation of HIV-1 from Latent Infection via Synergy of RUNX1 Inhibitor Ro5-3335 and SAHA. Klase, Z., V.S. Yedavalli, L. Houzet, M. Perkins, F. Maldarelli, J. Brenchley, K. Strebel, P. Liu, and K.T. Jeang. Plos Pathogens, 2014. 10(3): p. e1003997. PMID[24651404].
[PubMed]. HIV_0314-032714.
2. Postexposure Protection of Macaques from Vaginal SHIV Infection by Topical Integrase Inhibitors. Dobard, C., S. Sharma, U.M. Parikh, R. West, A. Taylor, A. Martin, C.P. Pau, D.L. Hanson, J. Lipscomb, J. Smith, F. Novembre, D. Hazuda, J.G. Garcia-Lerma, and W. Heneine. Science Translational Medicine, 2014. 6(227): p. 227ra35. PMID[24622515].
[PubMed]. HIV_0314-032714.
3. Discovery of 2-Pyridone Derivatives as Potent HIV-1 NNRTIs Using Molecular Hybridization Based on Crystallographic Overlays. Chen, W., P. Zhan, D. Rai, E. De Clercq, C. Pannecouque, J. Balzarini, Z. Zhou, H. Liu, and X. Liu. Bioorganic & Medicinal Chemistry, 2014. 22(6): p. 1863-1872. PMID[24581546].
[PubMed]. HIV_0314-032714.
ISI Web of Knowledge Citations
4. An Extracellular Laccase with Antiproliferative Activity from the Sanghuang Mushroom Inonotus baumii. Sun, J., Q.J. Chen, M.J. Zhu, H.X. Wang, and G.Q. Zhang. Journal of Molecular Catalysis B-Enzymatic, 2014. 99: p. 20-25. ISI[000331340500004].
[WOS]. HIV_0314-032714.
5. Formulation and Evaluation of Mucoadhesive Microspheres of Tenofovir disoproxil fumarate for Intravaginal Use. Khan, A.B. and R.S. Thakur. Current Drug Delivery, 2014. 11(1): p. 112-122. ISI[000331880600009].
[WOS]. HIV_0314-032714.
6. Cyclophilin a Promotes HIV-1 Reverse Transcription but Its Effect on Transduction Correlates Best with Its Effect on Nuclear Entry of Viral cDNA.De Iaco, A. and J. Luban. Retrovirology, 2014. 11. ISI[000331702100001].
[WOS]. HIV_0314-032714.
Patent Citations
7. Preparation of Substituted Naphthyridinedione Derivatives as HIV Integrase Inhibitors.Coleman, P.J., M. Embrey, T.J. Hartingh, D. Powell, I.T. Raheem, R.K. Chang, J. Schreier, J. Sisko, T. Steele, and A. Walji. Patent. 2014. 2013-US51494 2014018449: 69pp.
[Patent]. HIV_0314-032714.
8. Multi-substituted Amine Compounds as HIV Integrase Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of AIDS.Long, Y. and B. Cao. Patent. 2014. 2012-10269204 103570683: 116pp.
[Patent]. HIV_0314-032714.
9. Small Molecule Inhibitors of Viral Protein Interactions with Human t-RNA.Vendeix, F.A. and P.F. Agris. Patent. 2014. 2013-US53747 2014025749: 81pp.
[Patent]. HIV_0314-032714.
10. Preparation of Tricyclic Alkenylpyrrolopyridine Derivatives and Analogs for Use as HIV Attachment Inhibitors. Wang, T., J.F. Kadow, N.A. Meanwell, Z. Zhang, Z. Yin, E.H. Ruediger, C.A. James, and D.H. Deon. Patent. 2014. 2013-US53901 2014025852: 82pp.
[Patent]. HIV_0314-032714.
11. Preparation of Piperidinylamide Derivatives for Use as HIV Attachment Inhibitors.Wang, T., Z. Zhang, J.F. Kadow, N.A. Meanwell, E.H. Ruediger, C.A. James, D.H. Deon, D.J. Carini, and B.L. Johnson. Patent. 2014. 2013-US53903 2014025854: 93pp.
[Patent]. HIV_0314-032714.
12. Preparation of Tricyclic Amidinylindole Derivatives and Analogs for Use as HIV Attachment Inhibitors. Wang, T., Z. Zhang, Z. Yin, J.F. Kadow, and N.A. Meanwell. Patent. 2014. 2013-US53899 2014025850: 78pp.
[Patent]. HIV_0314-032714.
13. Compounds of Diarylanilines and Diarylpyridinamines, Preparation Method and Application.Xie, L., C.-H. Chen, L. Sun, and N. Liu. Patent. 2014. 2013-CN79342 2014012466: 60pp.
[Patent]. HIV_0314-032714.
14. Preparation of Diarylaniline or Diarylpyridinamine Derivatives as anti-HIV Agents.Xie, L., C.-H. Chen, L. Sun, and N. Liu. Patent. 2014. 2013-CN79345 2014012467: 62pp.
[Patent]. HIV_0314-032714.
15. Tenofovir Diesters Compounds with Activity for Inhibiting HIV-1 Virus Replication, and the Preparation Method and Pharmaceutical Application Thereof.You, G., H. Liu, and S. Yang. Patent. 2014. 2013-CN81304 2014026582: 47pp.
[Patent]. HIV_0314-032714.